Cargando…

Boron Clusters as Enhancers of RNase H Activity in the Smart Strategy of Gene Silencing by Antisense Oligonucleotides

Boron cluster-conjugated antisense oligonucleotides (B-ASOs) have already been developed as therapeutic agents with “two faces”, namely as potential antisense inhibitors of gene expression and as boron carriers for boron neutron capture therapy (BNCT). The previously observed high antisense activity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaniowski, Damian, Kulik, Katarzyna, Suwara, Justyna, Ebenryter-Olbińska, Katarzyna, Nawrot, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603397/ https://www.ncbi.nlm.nih.gov/pubmed/36293047 http://dx.doi.org/10.3390/ijms232012190

Ejemplares similares

EGFR-Targeted Cellular Delivery of Therapeutic Nucleic Acids Mediated by Boron Clusters
por: Kaniowski, Damian, et al.
Publicado: (2022)

Composites of Nucleic Acids and Boron Clusters (C(2)B(10)H(12)) as Functional Nanoparticles for Downregulation of EGFR Oncogene in Cancer Cells
por: Kaniowski, Damian, et al.
Publicado: (2021)

High Boron-loaded DNA-Oligomers as Potential Boron Neutron Capture Therapy and Antisense Oligonucleotide Dual-Action Anticancer Agents (‡)
por: Kaniowski, Damian, et al.
Publicado: (2017)

Metallacarborane Complex Boosts the Rate of DNA Oligonucleotide Hydrolysis in the Reaction Catalyzed by Snake Venom Phosphodiesterase
por: Kaniowski, Damian, et al.
Publicado: (2020)

Formation of an RNA Quadruplex-Duplex Hybrid in Living Cells between mRNA of the Epidermal Growth Factor Receptor (EGFR) and a G-Rich Antisense Oligoribonucleotide
por: Gudanis, Dorota, et al.
Publicado: (2020)

C5-substituents of uridines and 2-thiouridines present at the wobble position of tRNA determine the formation of their keto-enol or zwitterionic forms - a factor important for accuracy of reading of guanosine at the 3΄-end of the mRNA codons
por: Sochacka, Elzbieta, et al.
Publicado: (2017)

Hydrogen peroxide-triggered gene silencing in mammalian cells through boronated antisense oligonucleotides
por: Mori, Shohei, et al.
Publicado: (2017)

RNase H sequence preferences influence antisense oligonucleotide efficiency
por: Kiełpiński, Łukasz J., et al.
Publicado: (2017)

RNase H sequence preferences influence antisense oligonucleotide efficiency
por: Kiełpiński, Łukasz J, et al.
Publicado: (2019)

Silencing Antibiotic Resistance with Antisense Oligonucleotides
por: Jani, Saumya, et al.
Publicado: (2021)

Identifying and avoiding off-target effects of RNase H-dependent antisense oligonucleotides in mice
por: Hagedorn, Peter H, et al.
Publicado: (2018)

Application of 2′-O-(2-N-Methylcarbamoylethyl) Nucleotides in RNase H-Dependent Antisense Oligonucleotides
por: Masaki, Yoshiaki, et al.
Publicado: (2018)

Antiviral Efficacy of RNase H-Dependent Gapmer Antisense Oligonucleotides against Japanese Encephalitis Virus
por: Okamoto, Shunsuke, et al.
Publicado: (2023)

Molecular Mechanisms of Specific Cellular DNA Damage Response and Repair Induced by the Mixed Radiation Field During Boron Neutron Capture Therapy
por: Maliszewska-Olejniczak, Kamila, et al.
Publicado: (2021)

Translation can affect the antisense activity of RNase H1-dependent oligonucleotides targeting mRNAs
por: Liang, Xue-Hai, et al.
Publicado: (2018)

The rates of the major steps in the molecular mechanism of RNase H1-dependent antisense oligonucleotide induced degradation of RNA
por: Vickers, Timothy A., et al.
Publicado: (2015)

RNase H1-Dependent Antisense Oligonucleotides Are Robustly Active in Directing RNA Cleavage in Both the Cytoplasm and the Nucleus
por: Liang, Xue-Hai, et al.
Publicado: (2017)

The atlas of RNase H antisense oligonucleotide distribution and activity in the CNS of rodents and non-human primates following central administration
por: Jafar-nejad, Paymaan, et al.
Publicado: (2020)

Multi-Functionalized Heteroduplex Antisense Oligonucleotides for Targeted Intracellular Delivery and Gene Silencing in HeLa Cells
por: Sousa de Almeida, Mauro, et al.
Publicado: (2022)

A cytoplasmic pathway for gapmer antisense oligonucleotide-mediated gene silencing in mammalian cells
por: Castanotto, Daniela, et al.
Publicado: (2015)

Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis
por: Korobeynikov, Vladislav A., et al.
Publicado: (2022)

The Challenges and Strategies of Antisense Oligonucleotide Drug Delivery
por: Gagliardi, Maria, et al.
Publicado: (2021)

Antisense oligonucleotides in neurological disorders
por: Wurster, Claudia D., et al.
Publicado: (2018)

Molecular Mechanisms of Antisense Oligonucleotides
por: Crooke, Stanley T.
Publicado: (2017)

Antisense oligonucleotides: A primer
por: Scoles, Daniel R., et al.
Publicado: (2019)

Antisense Oligonucleotides and RNA Interference
por: Kher, Gitanjali, et al.
Publicado: (2011)

Liposome-coated lipoplex–based carrier for antisense oligonucleotides
por: Wyrozumska, Paulina, et al.
Publicado: (2014)

Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents
por: Stein, C. A., et al.
Publicado: (2010)

Antisense Oligonucleotides Capable of Promoting Specific Target mRNA Reduction via Competing RNase H1-Dependent and Independent Mechanisms
por: Vickers, Timothy A., et al.
Publicado: (2014)

Antisense oligonucleotides: a novel Frontier in pharmacological strategy
por: Collotta, D., et al.
Publicado: (2023)

Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides
por: Lennox, Kim A., et al.
Publicado: (2016)

The use of nano-sized acicular material, sliding friction, and antisense DNA oligonucleotides to silence bacterial genes
por: Mitsudome, Yuya, et al.
Publicado: (2014)

Foxp3 Silencing with Antisense Oligonucleotide Improves Immunogenicity of an Adjuvanted Recombinant Vaccine against Sporothrix schenckii
por: Batista-Duharte, Alexander, et al.
Publicado: (2021)

Intratracheally administered LNA gapmer antisense oligonucleotides induce robust gene silencing in mouse lung fibroblasts
por: Shin, Minwook, et al.
Publicado: (2022)

Opportunities and challenges for antisense oligonucleotide therapies
por: Kuijper, Elsa C., et al.
Publicado: (2020)

Drug Discovery Perspectives of Antisense Oligonucleotides
por: Kim, Yeonjoon
Publicado: (2023)

In-silico study of antisense oligonucleotide antibiotics
por: Chen, Erica S., et al.
Publicado: (2023)

Hybrid splicing minigene and antisense oligonucleotides as efficient tools to determine functional protein/RNA interactions
por: Cywoniuk, Piotr, et al.
Publicado: (2017)

Reduction of Off-Target Effects of Gapmer Antisense Oligonucleotides by Oligonucleotide Extension
por: Yasuhara, Hidenori, et al.
Publicado: (2022)

Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides
por: Juliano, Rudy, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_m7g0qlv6densridleu1tf2rukt